"Cambridge Biotech Cyclana Bio Secures Investment to Revolutionize Women's Health with Innovative Therapies for Endometriosis"

"Cyclana Bio, a biotech company based in Cambridge, has received investment to advance its innovative tissue-level therapeutics aimed at transforming women's health, particularly in treating endometriosis, a chronic condition affecting 1 in 10 women worldwide. The funding will help develop functional disease models and enhance the company's research on the extracellular matrix (ECM), which plays a crucial role in inflammation and tissue issues related to endometriosis. The company's unique approach combines menstrual fluid with lab modeling and AI to identify early disease indicators and potential drug targets. The investment was co-led by NfX and Eka VC, with support from other investors."

**Law Firms Involved in the Transaction:** The law firms that participated in the transaction include Mills & Reeve, which assisted Cyclana Bio, and other firms that may have supported the co-leading investors, NfX and Eka VC, as well as Cocoa VC, Wilbe, and a group of angel investors. **Transaction Overview:** Cyclana Bio, a Cambridge-based biotech company, secured investment to advance its innovative tissue-level therapeutics aimed at transforming women’s health, with an initial focus on endometriosis. This chronic condition affects 1 in 10 women globally, and the investment will help develop functional disease models that utilize tissue-level therapeutics to target the underlying issues of endometriosis. The company’s research emphasizes the extracellular matrix (ECM) and employs a pioneering methodology that combines donated menstrual fluid with lab-based modeling and AI to identify early disease indicators and potential drug targets. **Lawyers Involved:** Edward Sloan, head of venture capital investments at Mills & Reeve’s London office, played a key role in the transaction. His team provided significant support and guidance throughout the negotiation process. Further details regarding additional lawyers from Mills & Reeve or other law firms involved in the transaction, including their seniority and practice areas, were not specified in the press release.

"Cambridge Biotech Cyclana Bio Secures Investment to Revolutionize Women's Health with Innovative Therapies for Endometriosis"

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads